Literature DB >> 16466317

Neural stimulation for Parkinson's disease: current therapies and future directions.

Joseph S Neimat1, Clement Hamani, Andres M Lozano.   

Abstract

Neural stimulation has rapidly become an integral tool in the treatment of Parkinson's disease and other movement disorders. Today it serves as an important adjunct to medical therapy that continues to gain applicability to patients in whom the disease has progressed significantly. Studies have demonstrated efficacy in several deep-brain targets, with prolonged benefit exceeding 5-year follow-up times. Continuing study is teaching us more about the mechanism of deep-brain stimulation effect. New targets, which may treat the disease more successfully, are being examined. In this review, the history of deep-brain stimulation, the rationale for the known targets of stimulation; the clinical evidence demonstrating their benefit and, finally, future perspectives on new treatments that are being investigated and may have an impact on the field are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16466317     DOI: 10.1586/14737175.6.1.101

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  1 in total

1.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss.

Authors:  A L Spieles-Engemann; M M Behbehani; T J Collier; S L Wohlgenant; K Steece-Collier; K Paumier; B F Daley; S Gombash; L Madhavan; G T Mandybur; J W Lipton; B T Terpstra; C E Sortwell
Journal:  Neurobiol Dis       Date:  2010-03-20       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.